Cargando…

Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs

Along with the improvement of survival after cancer, cardiotoxicity due to antineoplastic treatments has emerged as a clinically relevant problem. Potential cardiovascular toxicities due to anticancer agents include QT prolongation and arrhythmias, myocardial ischemia and infarction, hypertension an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molinaro, Marilisa, Ameri, Pietro, Marone, Giancarlo, Petretta, Mario, Abete, Pasquale, Di Lisa, Fabio, De Placido, Sabino, Bonaduce, Domenico, Tocchetti, Carlo G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637019/ https://www.ncbi.nlm.nih.gov/pubmed/26583088 http://dx.doi.org/10.1155/2015/138148

Ejemplares similares

Mitral peak early diastolic filling velocity to deceleration time ratio as a predictor of prognosis in patients with chronic heart failure and preserved or reduced ejection fraction
por: Pirozzi, Flora, et al.
Publicado: (2015)

Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment
por: Attanasio, Umberto, et al.
Publicado: (2020)

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)

Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017)

Cardiac sympathetic dysfunction in pulmonary arterial hypertension: lesson from left-sided heart failure
por: Mercurio, Valentina, et al.
Publicado: (2019)

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
por: Pirozzi, Flora, et al.
Publicado: (2021)

Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed
por: Passaro, Fabiana, et al.
Publicado: (2017)

Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes
por: Testa, Gianluca, et al.
Publicado: (2020)

Physical vs. multidimensional frailty in older adults with and without heart failure
por: Testa, Gianluca, et al.
Publicado: (2020)

Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis
por: Dini, Frank L., et al.
Publicado: (2022)

Antineoplastics: Severe combined immmune dysfunction: case report
Publicado: (2018)

Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs
por: Todorov, Lozan, et al.
Publicado: (2023)

A common polymorphism in the SCN5A gene is associated with dilated cardiomyopathy
por: Mazzaccara, Cristina, et al.
Publicado: (2018)

Electrolyte Disorders Induced by Antineoplastic Drugs
por: Verzicco, Ignazio, et al.
Publicado: (2020)

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products
por: Trendowski, Matthew
Publicado: (2015)

Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events
por: Poto, Remo, et al.
Publicado: (2022)

Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients
por: Mercurio, Valentina, et al.
Publicado: (2019)

Depression and chronic heart failure in the elderly: an intriguing relationship
por: Liguori, Ilaria, et al.
Publicado: (2018)

Oxidative stress, aging, and diseases
por: Liguori, Ilaria, et al.
Publicado: (2018)

Sarcopenia: assessment of disease burden and strategies to improve outcomes
por: Liguori, Ilaria, et al.
Publicado: (2018)

Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990)

A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013)

MicroRNA in cancer: New hopes for antineoplastic chemotherapy
por: Di Leva, Gianpiero, et al.
Publicado: (2012)

Validation of “(fr)AGILE”: a quick tool to identify multidimensional frailty in the elderly
por: Liguori, Ilaria, et al.
Publicado: (2020)

Nodding syndrome: recent insights into etiology, pathophysiology, and treatment
por: Mwaka, Amos Deogratius, et al.
Publicado: (2018)

Clinical Pharmacology of Antineoplastic Drugs
por: Stewart, A.
Publicado: (1979)

Antineoplastic activity of idazoxan hydrochloride
por: Eilon, G. F., et al.
Publicado: (2009)

Antineoplastic Effects of Honokiol on Melanoma
por: Guillermo-Lagae, Ruth, et al.
Publicado: (2017)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

Pulmonary Effects of Antineoplastic Therapy
por: Dhakal, Sughosh, et al.
Publicado: (2015)

Endocrine Toxicities of Antineoplastic Therapy
por: Puliani, Giulia, et al.
Publicado: (2021)

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Ocular complications of antineoplastic therapies
por: Bader, Abbas, et al.
Publicado: (2023)

Recent advances on the role of monoamine oxidases in cardiac pathophysiology
por: Kaludercic, Nina, et al.
Publicado: (2023)

Syncope and Epilepsy coexist in ‘possible’ and ‘drug-resistant’ epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)
por: Ungar, Andrea, et al.
Publicado: (2017)

Mitochondrial Dysfunction in PCOS: Insights into Reproductive Organ Pathophysiology
por: Siemers, Kyle M., et al.
Publicado: (2023)

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
por: Marone, Giancarlo, et al.
Publicado: (2019)

Sarcopenia and Heart Failure
por: Curcio, Francesco, et al.
Publicado: (2020)

New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management
por: Cuomo, Alessandra, et al.
Publicado: (2021)

Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_10fekqvmveefc0anlejp637qrl